Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension

被引：32

作者：

Affuso, F ^{[1
]}

Palmieri, EA ^{[1
]}

Di Conza, P ^{[1
]}

Guardasole, V ^{[1
]}

Fazio, S ^{[1
]}

机构：

[1] Univ Naples Federico II, Sch Med, Dept Clin Med & Cardiovasc Sci, I-80131 Naples, Italy

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2006年 / 108卷 / 03期

关键词：

pulmonary arterial hypertension; selective inhibitors; endogenous vasodilators;

D O I：

10.1016/j.ijcard.2005.08.051

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pulmonary arterial hypertension has a poor prognosis quoad vitam et valitudinem. Herein, we report on a middle-aged woman affected by idiopathic pulmonary arterial hypertension whose quality of life and exercise tolerance improved remarkably after a six-month course of treatment with the long-acting phosphodiesterase-5 inhibitor tadalafil. (c) 2005 Elsevier Ireland Ltd. All rights reserved.

引用

页码：429 / 431

页数：3

共 9 条

[1] Sitaxsentan therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

Langleben, D ;

Frost, A ;

Horn, EM ;

Oudiz, R ;

Shapiro, S ;

McLaughlin, V ;

Hill, N ;

Tapson, VF ;

Robbins, IM ;

Zwicke, D ;

Duncan, B ;

Dixon, RAF ;

Frumkin, LR .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (04) :441-447

[2] Beraprost therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

McGoon, M ;

McLaughlin, V ;

Tapson, V ;

Oudiz, R ;

Shapiro, S ;

Robbins, IM ;

Channick, R ;

Badesch, D ;

Rayburn, BK ;

Flinchbaugh, R ;

Sigman, J ;

Arneson, C ;

Jeffs, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2119-2125

[3] Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses [J].

Brock, GB ;

McMahon, CG ;

Chen, KK ;

Costigan, T ;

Shen, W ;

Watkins, V ;

Anglin, G ;

Whitaker, S .

JOURNAL OF UROLOGY, 2002, 168 (04) :1332-1336

[4] Use of sildenafil (Viagra) in patients with cardiovascular disease [J].

Cheitlin, MD ;

Hutter, AM ;

Brindis, RG ;

Ganz, P ;

Kaul, S ;

Russell, RO ;

Zusman, RM ;

Forrester, JS ;

Douglas, PS ;

Faxon, DP ;

Fisher, JD ;

Gibbons, RJ ;

Halperin, JL ;

Hochman, JS ;

Kaul, S ;

Weintraub, WS ;

Winters, WL ;

Wolk, MJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (01) :273-282

[5] Efficacy and optimal dose of sildenafil in primary pulmonary hypertension [J].

Chockalingam, A ;

Gnanavelu, G ;

Venkatesan, S ;

Elangovan, S ;

Jagannathan, V ;

Subramaniam, T ;

Alagesan, R ;

Dorairajan, S .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 99 (01) :91-95

[6] Guidelines on diagnosis and treatment of pulmonary arterial hypertension -: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology [J].

Galiè, N ;

Torbicki, A ;

Barst, R ;

Dartevelle, P ;

Haworth, S ;

Higenbottam, T ;

Olschewski, H ;

Peacock, A ;

Pietra, G ;

Rubin, LJ ;

Simonneau, G .

EUROPEAN HEART JOURNAL, 2004, 25 (24) :2243-2278

[7] Idiopathic pulmonary arterial hypertension: current state of play and new treatment modalities [J].

Gibbs, JSR ;

Broberg, CS ;

Gatzoulls, MA .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 97 :7-10

[8] Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension [J].

Karatza, AA ;

Bush, A ;

Magee, AG .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 100 (02) :267-273

[9] Tadalafil in primary pulmonary arterial hypertension [J].

Palmieri, EA ;

Affuso, F ;

Fazio, S ;

Lembo, D .

ANNALS OF INTERNAL MEDICINE, 2004, 141 (09) :743-744

← 1 →